9Followers on Owler
Abide Therapeutics, Inc.
Abide is a biotechnology company that develops and commercializes serine hydrolase inhibitors for the treatment of neurological diseases.
Read more
Funding
$2.2M
Industry
Sector
Looking for similar companies to Abide Therapeutics, Inc.?
Abide Therapeutics, Inc. News
Abide Therapeutics, Inc. Press Releases
Abide Therapeutics, Inc. Headquarters
Abide Therapeutics, Inc. Summary
ABOUT
Overview
Abide is a biotechnology company that develops and commercializes serine hydrolase inhibitors for the treatment of neurological diseases. Abide Therapeutics, Inc. was founded in 2011. Abide Therapeutics, Inc.'s headquarters is located in Princeton, Ne...CEO
Abide Therapeutics, Inc.'s President & CEO, Alan Ezekowitz, currently has an approval rating of 84%. Abide Therapeutics, Inc.'s primary competitors are NexImmune, Vividion & Crinetics.Website
abidetx.comAcquisitions
There have been no acquisitions found related to Abide Therapeutics, Inc.Investments
Recent investment data cannot be found related to Abide Therapeutics, Inc.Frequently Asked Questions about Abide Therapeutics, Inc.
When was Abide Therapeutics, Inc. founded?
Abide Therapeutics, Inc. was founded in 2011Who is Abide Therapeutics, Inc.'s CEO?
Abide Therapeutics, Inc.'s CEO is Alan EzekowitzHow much revenue does Abide Therapeutics, Inc. generate?
Abide Therapeutics, Inc. generates $5.2M in revenueHow much funding does Abide Therapeutics, Inc. have?
Abide Therapeutics, Inc. has historically raised $2.2M in funding
Where is Abide Therapeutics, Inc.'s headquarters?
Abide Therapeutics, Inc.'s headquarters is in Princeton New Jersey, USAHow many employees does Abide Therapeutics, Inc. have?
Abide Therapeutics, Inc. has 40 employeesWhat sector does Abide Therapeutics, Inc. operate in?
Abide Therapeutics, Inc. is in BiotechnologyWho are Abide Therapeutics, Inc.'s competitors?
Abide Therapeutics, Inc.'s top competitors are NexImmune, Vividion, Crinetics